Overview

A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNV

Status:
Unknown status

Trial end date:
2015-03-01

Target enrollment:

Participant gender:

Summary

This study is design to evaluate the effect of conbercept therapy on visual acuity and anatomic outcomes compared to sham injection and durability of response observed in subjects with choroid neovascularization secondary to pathological myopia.

Phase:

Phase 3

Details

Lead Sponsor:

Chengdu Kanghong Biotech Co., Ltd.
Chengdu Kanghong Biotech Co.,Ltd.